Ultibro Breezhaler 50 mcg (Glycopyrronium (Glycopyrronium Bromide) CAPSULE) 50 MCG

Ultibro Breezhaler 50 mcg capsules are a prescription medication used for managing chronic obstructive pulmonary disease (COPD). This inhalation treatment combines glycopyrronium to help improve breathing and reduce symptoms.

Strength

50 MCG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ultibro Breezhaler 50 mcg capsules are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to help manage symptoms such as shortness of breath, wheezing, and coughing. It works by relaxing the airways, making it easier to breathe. People often ask, 'What is Ultibro Breezhaler used for?' and the answer is that it is intended for long-term use in COPD management, not for immediate relief of sudden symptoms.

Side Effects

Common effects of Ultibro Breezhaler 50 mcg capsules may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects vary from person to person and are not experienced by everyone. If any effects are severe or persistent, it is important to consult a healthcare provider.

Precautions & Warnings

Ultibro Breezhaler 50 mcg capsules should be used with caution in people with certain medical conditions, such as heart disease or glaucoma. It is important to follow the prescribed dosage and administration instructions carefully. The capsules should be stored in a dry place and used as directed. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Ultibro Breezhaler 50 mcg capsules may interact with other medications, including beta-blockers and anticholinergics. It is important to avoid using this medication with other long-acting anticholinergics to prevent potential adverse effects. Always consult a healthcare provider before starting any new medication while using Ultibro Breezhaler.

Frequently Asked Questions

Ultibro Breezhaler 50 mcg capsules are used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

Ultibro Breezhaler 50 mcg capsules are designed for inhalation use. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness.

Ultibro Breezhaler 50 mcg capsules are specifically indicated for COPD and not for asthma. Consult a healthcare provider for appropriate treatment options.

Ultibro Breezhaler 50 mcg capsules should be stored in a dry place at room temperature, away from moisture and heat.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.